Amoxicillin indications: Difference between revisions
MisheltK0Ls (talk | contribs) No edit summary |
m (Reverted edits by MisheltK0Ls (talk) to last revision by NNethala) |
||
| Line 1: | Line 1: | ||
{{CMG}} | {{CMG}} | ||
==List of | ==List of indications== | ||
<font size="4">[[Amoxicillin indications#AMOXIL|AMOXIL]]'''</font> | <font size="4">[[Amoxicillin indications#AMOXIL|AMOXIL]]'''</font> | ||
<br> | <br> | ||
| Line 9: | Line 9: | ||
<br> | <br> | ||
<br> | <br> | ||
<font size="4">[[Amoxicillin indications#H. pylori eradication to reduce the risk of duodenal ulcer recurrence Triple therapy(AMOXIL/clarithromycin/lansoprazole)|H. pylori eradication to reduce the risk of duodenal ulcer recurrence Triple therapy(AMOXIL/clarithromycin/lansoprazole)]]'''</font> | <font size="4">[[Amoxicillin indications#H. pylori eradication to reduce the risk of duodenal ulcer recurrence Triple therapy (AMOXIL/clarithromycin/lansoprazole)|H. pylori eradication to reduce the risk of duodenal ulcer recurrence Triple therapy(AMOXIL/clarithromycin/lansoprazole)]]'''</font> | ||
<br> | <br> | ||
<br> | <br> | ||
<font size="4">[[Amoxicillin indications#Dual therapy(AMOXIL/lansoprazole)|Dual therapy(AMOXIL/lansoprazole)]]'''</font> | <font size="4">[[Amoxicillin indications#Dual therapy (AMOXIL/lansoprazole)|Dual therapy(AMOXIL/lansoprazole)]]'''</font> | ||
<br> | <br> | ||
---- | ---- | ||
| Line 23: | Line 23: | ||
modifying antibacterial therapy. In the absence of such data, local epidemiology and | modifying antibacterial therapy. In the absence of such data, local epidemiology and | ||
susceptibility patterns may contribute to the empiric selection of therapy. | susceptibility patterns may contribute to the empiric selection of therapy. | ||
Indicated surgical procedures should be performed. AMOXIL is indicated in the treatment of infections due to susceptible (ONLY β-lactamase–negative) strains of the designated microorganisms. | Indicated surgical procedures should be performed. AMOXIL is indicated in the treatment of infections due to susceptible (ONLY β-lactamase–negative) strains of the designated microorganisms. ''[[Amoxicillin indications#List of indications|Return to top]]'' | ||
<br> | |||
===Infections of the ear, nose, and throat=== | ===Infections of the ear, nose, and throat=== | ||
Amoxicillin is indicated in the infections of the ear, nose, and throatdue to Streptococcus spp. (α- and β-hemolytic | Amoxicillin is indicated in the infections of the ear, nose, and throatdue to Streptococcus spp. (α- and β-hemolytic | ||
strains only), S. pneumoniae, Staphylococcus spp., or H. influenzae. | strains only), S. pneumoniae, Staphylococcus spp., or H. influenzae. ''[[Amoxicillin indications#List of indications|Return to top]]'' | ||
<br> | |||
===Infections of the genitourinary tract=== | ===Infections of the genitourinary tract=== | ||
Amoxicillin is indicated in the infections of the genitourinary tract due to E. coli, P. mirabilis, or E. faecalis. | Amoxicillin is indicated in the infections of the genitourinary tract due to E. coli, P. mirabilis, or E. faecalis. ''[[Amoxicillin indications#List of indications|Return to top]]'' | ||
<br> | |||
===Infections of the skin and skin structure=== | ===Infections of the skin and skin structure=== | ||
Amoxicillin is indicated in the infections of the skin and skin structure due to Streptococcus spp. (α- and β-hemolytic | Amoxicillin is indicated in the infections of the skin and skin structure due to Streptococcus spp. (α- and β-hemolytic | ||
strains only), Staphylococcus spp., or E. coli. | strains only), Staphylococcus spp., or E. coli. ''[[Amoxicillin indications#List of indications|Return to top]]'' | ||
<br> | |||
===Infections of the lower respiratory tract=== | ===Infections of the lower respiratory tract=== | ||
Amoxicillin is indicated in the infections of the lower respiratory tract due to Streptococcus spp. (α- and β-hemolytic | Amoxicillin is indicated in the infections of the lower respiratory tract due to Streptococcus spp. (α- and β-hemolytic | ||
strains only), S. pneumoniae, Staphylococcus spp., or H. influenzae. | strains only), S. pneumoniae, Staphylococcus spp., or H. influenzae. | ||
Gonorrhea, acute uncomplicated (ano-genital and urethral infections) – due to | Gonorrhea, acute uncomplicated (ano-genital and urethral infections) – due to | ||
N. gonorrhoeae (males and females). | N. gonorrhoeae (males and females). ''[[Amoxicillin indications#List of indications|Return to top]]'' | ||
<br> | |||
===H. pylori eradication to reduce the risk of duodenal ulcer recurrence Triple therapy(AMOXIL/clarithromycin/lansoprazole)=== | ===H. pylori eradication to reduce the risk of duodenal ulcer recurrence Triple therapy (AMOXIL/clarithromycin/lansoprazole)=== | ||
AMOXIL, in combination with clarithromycin plus lansoprazole as triple therapy, is indicated | AMOXIL, in combination with clarithromycin plus lansoprazole as triple therapy, is indicated | ||
for the treatment of patients with H. pylori infection and duodenal ulcer disease (active or 1-year | for the treatment of patients with H. pylori infection and duodenal ulcer disease (active or 1-year | ||
history of a duodenal ulcer) to eradicate H. pylori. Eradication of H. pylori has been shown to | history of a duodenal ulcer) to eradicate H. pylori. Eradication of H. pylori has been shown to | ||
reduce the risk of duodenal ulcer recurrence. | reduce the risk of duodenal ulcer recurrence. ''[[Amoxicillin indications#List of indications|Return to top]]'' | ||
<br> | |||
===Dual therapy(AMOXIL/lansoprazole)=== | ===Dual therapy (AMOXIL/lansoprazole)=== | ||
AMOXIL, in combination with lansoprazole delayed-release capsules as dual therapy, is | AMOXIL, in combination with lansoprazole delayed-release capsules as dual therapy, is | ||
indicated for the treatment of patients with H. pylori infection and duodenal ulcer disease (active | indicated for the treatment of patients with H. pylori infection and duodenal ulcer disease (active | ||
or 1-year history of a duodenal ulcer) who are either allergic or intolerant to clarithromycin | or 1-year history of a duodenal ulcer) who are either allergic or intolerant to clarithromycin | ||
or in whom resistance to clarithromycin is known or suspected. Eradication of H. pylori has been shown to reduce the risk | or in whom resistance to clarithromycin is known or suspected. Eradication of H. pylori has been shown to reduce the risk | ||
of duodenal ulcer recurrence. | of duodenal ulcer recurrence. ''[[Amoxicillin indications#List of indications|Return to top]]'' | ||
<br> | |||
<br> | |||
---- | |||
<br> | |||
{{FDA}} | |||
Latest revision as of 01:48, 19 December 2011
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
List of indications
- Infections of the ear, nose, and throat
- Infections of the genitourinary tract
- Infections of the skin and skin structure
- Infections of the lower respiratory tract
H. pylori eradication to reduce the risk of duodenal ulcer recurrence Triple therapy(AMOXIL/clarithromycin/lansoprazole)
Dual therapy(AMOXIL/lansoprazole)
AMOXIL
To reduce the development of drug-resistant bacteria and maintain the effectiveness of
AMOXIL and other antibacterial drugs, AMOXIL should be used only to treat or prevent
infections that are proven or strongly suspected to be caused by susceptible bacteria. When
culture and susceptibility information are available, they should be considered in selecting or
modifying antibacterial therapy. In the absence of such data, local epidemiology and
susceptibility patterns may contribute to the empiric selection of therapy.
Indicated surgical procedures should be performed. AMOXIL is indicated in the treatment of infections due to susceptible (ONLY β-lactamase–negative) strains of the designated microorganisms. Return to top
Infections of the ear, nose, and throat
Amoxicillin is indicated in the infections of the ear, nose, and throatdue to Streptococcus spp. (α- and β-hemolytic
strains only), S. pneumoniae, Staphylococcus spp., or H. influenzae. Return to top
Infections of the genitourinary tract
Amoxicillin is indicated in the infections of the genitourinary tract due to E. coli, P. mirabilis, or E. faecalis. Return to top
Infections of the skin and skin structure
Amoxicillin is indicated in the infections of the skin and skin structure due to Streptococcus spp. (α- and β-hemolytic
strains only), Staphylococcus spp., or E. coli. Return to top
Infections of the lower respiratory tract
Amoxicillin is indicated in the infections of the lower respiratory tract due to Streptococcus spp. (α- and β-hemolytic
strains only), S. pneumoniae, Staphylococcus spp., or H. influenzae.
Gonorrhea, acute uncomplicated (ano-genital and urethral infections) – due to
N. gonorrhoeae (males and females). Return to top
H. pylori eradication to reduce the risk of duodenal ulcer recurrence Triple therapy (AMOXIL/clarithromycin/lansoprazole)
AMOXIL, in combination with clarithromycin plus lansoprazole as triple therapy, is indicated
for the treatment of patients with H. pylori infection and duodenal ulcer disease (active or 1-year
history of a duodenal ulcer) to eradicate H. pylori. Eradication of H. pylori has been shown to
reduce the risk of duodenal ulcer recurrence. Return to top
Dual therapy (AMOXIL/lansoprazole)
AMOXIL, in combination with lansoprazole delayed-release capsules as dual therapy, is
indicated for the treatment of patients with H. pylori infection and duodenal ulcer disease (active
or 1-year history of a duodenal ulcer) who are either allergic or intolerant to clarithromycin
or in whom resistance to clarithromycin is known or suspected. Eradication of H. pylori has been shown to reduce the risk
of duodenal ulcer recurrence. Return to top
Adapted from the FDA Package Insert.